Financial Statements — ACRV
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 |
|---|
| Cash & Equivalents | 34.06 | 35.41 | 41.90 | 39.15 | 43.42 | 46.01 | 24.61 | 29.86 | 38.07 | 27.49 | 32.08 |
| Short-term Investments | 63.67 | 93.85 | 95.53 | 110.48 | 144.04 | 134.53 | 85.37 | 112.23 | 112.88 | 92.72 | -- |
| Total Current Assets | 99.22 | 130.36 | 138.41 | 151.33 | 188.98 | 182.36 | 112.14 | 144.49 | 153.28 | 123.96 | 78.67 |
| Property, Plant & Equipment | 4.65 | 5.19 | 5.07 | 4.68 | 4.67 | 3.47 | 3.41 | 2.00 | 1.98 | 1.99 | 2.15 |
| Total Non-current Assets* | 8.61 | 14.94 | 20.17 | 25.02 | 25.70 | 48.23 | 8.38 | 6.60 | 6.77 | 46.23 | 9.04 |
| Total Assets | 107.83 | 145.30 | 158.58 | 176.35 | 214.68 | 230.59 | 120.52 | 151.09 | 160.05 | 170.20 | 87.71 |
| Accounts Payable | 1.16 | 1.00 | 1.16 | 3.69 | 1.51 | 1.26 | 2.06 | 1.50 | 1.27 | 1.37 | 1.98 |
| Total Current Liabilities | 11.05 | 14.89 | 13.43 | 13.55 | 14.82 | 11.28 | 9.04 | 9.30 | 7.02 | 5.68 | 6.39 |
| Total Non-current Liabilities* | 1.26 | 1.81 | 2.12 | 2.41 | 2.97 | 3.24 | 3.50 | 3.64 | 3.85 | 4.05 | 4.42 |
| Total Liabilities | 12.32 | 16.70 | 15.55 | 15.96 | 17.79 | 14.53 | 12.54 | 12.94 | 10.87 | 9.73 | 10.81 |
| Retained Earnings | (293.92) | (255.90) | (237.66) | (216.66) | (174.14) | (151.70) | (132.91) | (97.17) | (82.70) | (68.79) | (47.10) |
| Total Stockholder Equity | 95.52 | 128.60 | 143.04 | 160.39 | 196.89 | 216.06 | 107.98 | 138.15 | 149.18 | 160.47 | (45.62) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 |
|---|
| Research & Development | 15.17 | 14.75 | 13.65 | 16.18 | 15.41 | 18.63 | 18.86 | 15.03 | 11.47 | 15.48 | -- | -- | -- | -- | -- |
| Selling, General & Admin | 4.74 | 5.37 | 6.04 | 6.47 | 6.25 | 6.32 | 6.28 | 6.41 | 6.20 | 5.58 | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.90 | 20.12 | 19.69 | 22.65 | 21.66 | 24.95 | 25.14 | 21.44 | 17.67 | 21.05 | 16.14 | 15.52 | 14.39 | 9.95 | 9.57 |
| Operating Income | (19.90) | (20.12) | (19.69) | (22.65) | (21.66) | (24.95) | (25.14) | (21.44) | (17.67) | (21.05) | (16.14) | (15.52) | (14.39) | (9.94) | (9.57) |
| Net Income | (19.04) | (18.98) | (18.23) | (21.01) | (19.68) | (22.83) | (22.44) | (18.80) | (16.49) | (19.25) | (14.47) | (13.91) | (12.76) | (8.93) | (9.20) |
| Basic EPS | (0.49) | (0.49) | (0.47) | (0.55) | (0.51) | (0.54) | (0.59) | (0.52) | (0.73) | (0.87) | (0.66) | (0.63) | (0.58) | 4.99 | (5.17) |
| Diluted EPS | (0.49) | (0.49) | (0.47) | (0.55) | (0.51) | (0.54) | (0.59) | (0.52) | (0.73) | (0.87) | (0.66) | (0.63) | (0.58) | 4.99 | (5.17) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 |
|---|
| Operating Cash Flow | (20.54) | (15.24) | (12.28) | (16.61) | (19.53) | (17.36) | (17.32) | (13.90) | (17.08) | (12.37) | (9.81) | (9.11) | (11.36) | (9.35) | (20.76) |
| Capital Expenditures | 0.01 | 0.22 | 0.90 | 0.49 | 0.06 | 0.83 | 0.99 | 0.14 | 0.82 | 1.15 | 0.00 | 0.11 | 0.03 | 0.25 | 1.92 |
| Free Cash Flow* | (20.55) | (15.46) | (13.18) | (17.10) | (19.59) | (18.19) | (18.31) | (14.04) | (17.90) | (13.52) | (9.81) | (9.22) | (11.38) | (9.60) | (22.68) |
| Investing Cash Flow | 13.13 | 21.52 | 5.91 | 19.45 | 19.21 | 14.41 | 16.01 | (88.04) | 5.85 | 20.54 | 1.52 | 19.34 | 9.33 | (95.07) | (46.61) |
| Financing Cash Flow | (0.03) | (0.19) | (0.12) | (0.10) | (0.34) | (0.65) | (1.50) | 123.35 | (0.17) | (2.01) | 0.08 | 0.38 | -- | 101.86 | (0.15) |
* Derived from reported values
